Rate of bleeding stratified by risk in patients with venous thromboembolism (VTE) on anticoagulation
Rate of bleeding stratified by risk in patients with venous thromboembolism (VTE) on anticoagulation
Bleeding risk
First 3 months
Annual rate after first 3 months
Low risk (no risk factors present)
1.6%
0.8%
Intermediate risk (one risk factor present)
3.2%
1.3%
High risk (two or more risk factors present)
12.8%
≥6.5%
Data from: Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.
